Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the Covid-19 Era
AuthID
P-00V-XM6
P-00V-XM6
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service